Lloyd J. Old, MD, Father of Modern Tumor Immunology, Dies at 78 of Prostate Cancer CRI announced today its founding scientific and medical director Lloyd J. Old, MD, regarded as the “Father... noviembre 28, 2011julio 13, 2022
Critical Value Demonstrated for Immune Assay Harmonization The Association for Cancer Immunotherapy Immunoguiding Program and the Cancer Immunotherapy Consortium of CRI published a joint... noviembre 9, 2011julio 13, 2022
Cancer Immunotherapy Consortium Appoints New Leadership Drs. James P. Allison, chair of the immunology program at Memorial Sloan-Kettering Cancer Center, and Axel Hoos,... noviembre 8, 2011julio 13, 2022
25th Annual CRI Awards Dinner Honors Outstanding Contributions to Cancer Immunotherapy CRI hosted its 25th Annual Awards Dinner on Monday, October 3, 2011, where 290 guests joined CRI... octubre 21, 2011julio 13, 2022
Collaborative Partnership Pioneers Model to Improve Clinical Success of Cancer Immunotherapies The Cancer Immunotherapy Consortium of the Cancer Research Institute and the Association for Cancer Immunotherapy have issued... octubre 18, 2011julio 13, 2022
Three Cancer Research Institute Scientists to Receive 2011 Nobel Prize in Physiology or Medicine The Nobel Foundation announced yesterday that CRI-funded scientists Drs. Bruce Beulter, Jules Hoffmann, and Ralph Steinman will... octubre 4, 2011julio 13, 2022
